Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Calreticulin antibody

The Rabbit Polyclonal anti-Calreticulin antibody has been validated for WB, FACS, IHC (p) and EIA. It is suitable to detect Calreticulin in samples from Human and Rat.
Catalog No. ABIN5540076

Quick Overview for Calreticulin antibody (ABIN5540076)

Target

See all Calreticulin (CALR) Antibodies
Calreticulin (CALR)

Reactivity

  • 137
  • 71
  • 66
  • 9
  • 9
  • 6
  • 6
  • 6
  • 5
  • 5
  • 4
  • 4
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
Human, Rat

Host

  • 136
  • 25
  • 2
  • 1
Rabbit

Clonality

  • 125
  • 39
Polyclonal

Conjugate

  • 96
  • 13
  • 12
  • 7
  • 5
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This Calreticulin antibody is un-conjugated

Application

  • 133
  • 87
  • 57
  • 49
  • 47
  • 42
  • 34
  • 14
  • 14
  • 13
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA)
  • Specificity

    This antibody detects Calreticulin. Species: Human, Rat.

    Purification

    Protein A column, followed by peptide affinity purification

    Immunogen

    This CALR Antibody is generated from rabbits immunized with a recombinant protein of human CALR.
  • Application Notes

    Western blot: 1/100-1/500. ELISA: 1/1,000. Flow Cytometry: 1/10-1/50. Immunohistochemistry on Paraffin Sections:

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    PBS with 0.09 % (W/V) sodium azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. Shelf life: one year from despatch.

    Expiry Date

    12 months
  • Target

    Calreticulin (CALR)

    Alternative Name

    calreticulin

    Background

    Calreticulin is a multifunctional protein that acts as a major Ca(2+)-binding (storage) protein in the lumen of the endoplasmic reticulum. It is also found in the nucleus, suggesting that it may have a role in transcription regulation. Calreticulin binds to the synthetic peptide KLGFFKR, which is almost identical to an amino acid sequence in the DNA-binding domain of the superfamily of nuclear receptors. Calreticulin binds to antibodies in certain sera of systemic lupus and Sjogren patients which contain anti-Ro/SSA antibodies, it is highly conserved among species, and it is located in the endoplasmic and sarcoplasmic reticulum where it may bind calcium. The amino terminus of calreticulin interacts with the DNA-binding domain of the glucocorticoid receptor and prevents the receptor from binding to its specific glucocorticoid response element. Calreticulin can inhibit the binding of androgen receptor to its hormone-responsive DNA element and can inhibit androgen receptor and retinoic acid receptor transcriptional activities in vivo, as well as retinoic acid-induced neuronal differentiation. Thus, calreticulin can act as an important modulator of the regulation of gene transcription by nuclear hormone receptors. Systemic lupus erythematosus is associated with increased autoantibody titers against calreticulin but calreticulin is not a Ro/SS-A antigen. Earlier papers referred to calreticulin as an Ro/SS-A antigen but this was later disproven. Increased autoantibody titer against human calreticulin is found in infants with complete congenital heart block of both the IgG and IgM classes.

    UniProt

    P27797

    Pathways

    Retinoic Acid Receptor Signaling Pathway, Intracellular Steroid Hormone Receptor Signaling Pathway, Regulation of Intracellular Steroid Hormone Receptor Signaling, Nuclear Hormone Receptor Binding, ER-Nucleus Signaling, Unfolded Protein Response
You are here:
Chat with us!